Developing a new platform for analyzing proteins in single cells.

SBIR PHASE II, TOPIC 420: INTEGRATED PLATFORM AND CONSUMABLES FOR ROBUST, SENSITIVE AND HIGH-THROUGHPUT SINGLE-CELL PROTEOMICS

NIH-funded research Micromics Technologies LLC · NIH-10948319

This study is working on a new system to make it easier for labs to study proteins in single cells, which could help improve medical research and personalized treatments for patients like you.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMicromics Technologies LLC NIH-funded
Lab location1 site (Spanish Fork, United States)
Project IDNIH-10948319 on NIH RePORTER

What this research studies

This research focuses on creating an integrated platform that simplifies the process of single-cell proteomics, which is the study of proteins in individual cells. It aims to develop specialized reagents and consumables that make sample preparation easier and more accessible for laboratories. The project will also create high-performance liquid chromatography columns and a multi-column platform to enhance the speed and efficiency of protein analysis. By achieving a high throughput of analyzing 96 cells per day, this research could significantly advance the fields of biomedical research, biomarker discovery, and personalized medicine.

Who could benefit from this research

Good fit: Ideal candidates for benefiting from this research include patients with conditions that require precise biomarker identification and individualized therapy.

Not a fit: Patients with conditions that do not involve protein analysis or do not require single-cell level insights may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could enable more laboratories to conduct detailed protein analyses at the single-cell level, leading to better diagnostics and personalized treatment options for patients.

How similar studies have performed: Other research has shown success in developing advanced proteomics techniques, but this specific approach to streamline single-cell analysis is relatively novel.

Where this research is happening

Spanish Fork, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.